PBLS — Parabilis Medicines, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1657677 ·
Last close
$31.78
Market Cap
—
52W High
$34.47
52W Low
$24.51
ADV30
657,647
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -47,453,000 | -45,316,000 | 384,173,000 | 329,039,000 | 139,953,000 |
| Mar 2025 | 0 | — | -40,241,000 | -38,326,000 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-83,354,000
Investing CF
$6,320,000
Financing CF
$418,186,000
CapEx
$-443,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-06-11
Balance + Analyst (yfinance extras)
Retained Earnings
$-586,820,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-82,951,000
Pretax Income TTM
$-83,642,000
Interest Exp TTM
$691,000
Analysts
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -152,079,000 | -145,889,000 | 80,820,000 | 97,344,000 | — | -123,713,000 |
| Dec 2024 | 0 | -126,125,000 | -117,914,000 | 149,253,000 | 92,814,000 | — | -103,613,000 |
Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $45.00 · spot: $31.78 · call volume: 2 · put volume: 5
Expected Move to 2027-02-19:
±$12.10
(38.07%) —
implied range
$19.68 –
$43.88
· ATM straddle on $30.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.08T | $1210.02 | — |
| JNJ | JOHNSON & JOHNSON | $639.90B | $265.53 | — |
| ABBV | AbbVie Inc. | $465.20B | $263.30 | — |
| MRK | Merck & Co., Inc. | $321.97B | $130.36 | — |
| NVS | NOVARTIS AG | $301.89B | $158.83 | — |
News headlines (Yahoo Finance, 1h cache)
Parabilis Medicines (PBLS) Stock Valuation After Recent 10% Single Day Decline
2026-06-15 21:14 · Yahoo
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
2026-06-11 20:05 · Yahoo
How to Play PBLS Stock After the Parabilis IPO
2026-06-11 19:12 · Yahoo
Parabilis Medicines Announces Pricing of Upsized Initial Public Offering
2026-06-10 00:22 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-07-22 16:55:48 | 2026-07-20 | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | 28.29 | 244593 | 6919551 |